1492 Capital Management LLC Has $4.67 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

1492 Capital Management LLC boosted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 16.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 52,884 shares of the company's stock after purchasing an additional 7,490 shares during the period. HealthEquity makes up approximately 2.5% of 1492 Capital Management LLC's holdings, making the stock its 12th biggest position. 1492 Capital Management LLC owned about 0.06% of HealthEquity worth $4,673,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in HQY. Transce3nd LLC acquired a new position in HealthEquity in the 4th quarter valued at approximately $29,000. Versant Capital Management Inc acquired a new position in HealthEquity in the 1st quarter valued at approximately $28,000. Larson Financial Group LLC increased its stake in HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after buying an additional 642 shares during the period. Huntington National Bank increased its stake in HealthEquity by 89.4% in the 4th quarter. Huntington National Bank now owns 767 shares of the company's stock valued at $74,000 after buying an additional 362 shares during the period. Finally, Whipplewood Advisors LLC increased its stake in HealthEquity by 5,060.0% in the 1st quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock valued at $68,000 after buying an additional 759 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

Insider Buying and Selling

In other HealthEquity news, Director Jon Kessler sold 97,767 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.05, for a total value of $10,954,792.35. Following the completion of the sale, the director owned 75,000 shares in the company, valued at approximately $8,403,750. This trade represents a 56.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of the firm's stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. The trade was a 43.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock worth $32,705,007 in the last quarter. 1.50% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have commented on the stock. The Goldman Sachs Group boosted their target price on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. KeyCorp decreased their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Raymond James Financial reissued a "strong-buy" rating and issued a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Royal Bank Of Canada boosted their target price on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. Finally, Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $118.55.

HealthEquity Price Performance

Shares of HQY stock traded up $1.66 during mid-day trading on Friday, reaching $96.04. The company's stock had a trading volume of 497,345 shares, compared to its average volume of 863,282. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $116.65. The company has a market cap of $8.31 billion, a P/E ratio of 70.10, a PEG ratio of 1.46 and a beta of 0.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. The firm's 50-day moving average is $101.54 and its two-hundred day moving average is $98.43.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The company had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same quarter in the prior year, the company posted $0.80 EPS. On average, research analysts predict that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.